Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Argus Health
Colorcon
QuintilesIMS
Baxter
Julphar
US Department of Justice
Cantor Fitzgerald
Accenture
Deloitte

Generated: October 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090326

« Back to Dashboard
NDA 090326 describes LIOTHYRONINE SODIUM, which is a drug marketed by X Gen Pharms, Mylan, Watson Labs, Sun Pharm Inds Ltd, Sigmapharm Labs Llc, and Mayne Pharma Inc, and is included in seven NDAs. It is available from eighteen suppliers. Additional details are available on the LIOTHYRONINE SODIUM profile page.

The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.

Summary for NDA: 090326

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
Formulation / Manufacturing:see details

Pharmacology for NDA: 090326

Ingredient-typeTriiodothyronine

Suppliers and Packaging for NDA: 090326

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIOTHYRONINE SODIUM
liothyronine sodium
TABLET;ORAL 090326 ANDA Mylan Pharmaceuticals Inc. 0378-3611 0378-3611-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-3611-01)
LIOTHYRONINE SODIUM
liothyronine sodium
TABLET;ORAL 090326 ANDA Mylan Pharmaceuticals Inc. 0378-3612 0378-3612-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-3612-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.005MG BASE
Approval Date:Jul 14, 2009TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.025MG BASE
Approval Date:Jul 14, 2009TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.05MG BASE
Approval Date:Jul 14, 2009TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Colorcon
Chubb
Mallinckrodt
Argus Health
Cerilliant
McKinsey
Deloitte
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot